Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""DIABETIC nephropathies"" wg kryterium: Temat


Tytuł:
Endothelial CXCR2 deficiency attenuates renal inflammation and glycocalyx shedding through NF-κB signaling in diabetic kidney disease.
Autorzy:
Cui S; Department of Endocrinology, The Affiliated Wuxi No.2 People's Hospital of Nanjing Medical University, Wuxi, China.; Department of Endocrinology, Jiangnan University Medical Center, Wuxi, China.
Chen X; Department of Endocrinology, The Affiliated Wuxi No.2 People's Hospital of Nanjing Medical University, Wuxi, China.; Department of Endocrinology, Jiangnan University Medical Center, Wuxi, China.; Nanjing Medical University, Nanjing, China.
Li J; Wuxi School of Medicine, Jiangnan University, Wuxi, China.
Wang W; Wuxi School of Medicine, Jiangnan University, Wuxi, China.
Meng D; Department of Endocrinology, The Affiliated Wuxi No.2 People's Hospital of Nanjing Medical University, Wuxi, China.; Department of Endocrinology, Jiangnan University Medical Center, Wuxi, China.; Wuxi School of Medicine, Jiangnan University, Wuxi, China.
Zhu S; Wuxi School of Medicine, Jiangnan University, Wuxi, China. .
Shen S; Department of Endocrinology, The Affiliated Wuxi No.2 People's Hospital of Nanjing Medical University, Wuxi, China. .; Department of Endocrinology, Jiangnan University Medical Center, Wuxi, China. .
Pokaż więcej
Źródło:
Cell communication and signaling : CCS [Cell Commun Signal] 2024 Mar 25; Vol. 22 (1), pp. 191. Date of Electronic Publication: 2024 Mar 25.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetic Nephropathies*/genetics
Diabetic Nephropathies*/metabolism
Diabetic Nephropathies*/pathology
NF-kappa B*/metabolism
Receptors, Interleukin-8B*/genetics
Receptors, Interleukin-8B*/metabolism
Animals ; Humans ; Mice ; Endothelial Cells/metabolism ; Endothelium/metabolism ; Glucose ; Glycocalyx/metabolism ; Inflammation/metabolism ; Mice, Knockout ; Receptors, Chemokine/therapeutic use ; Diabetes Complications/genetics ; Diabetes Complications/metabolism
Czasopismo naukowe
Tytuł:
A late eating midpoint is associated with increased risk of diabetic kidney disease: a cross-sectional study based on NHANES 2013-2020.
Autorzy:
Lu CF; Department of Endocrinology, Affiliated Hospital 2 of Nantong University and First People's Hospital of Nantong City, No. 666 Shengli Road, Nantong, 226001, China.
Cang XM; Department of Endocrinology, Affiliated Hospital 2 of Nantong University and First People's Hospital of Nantong City, No. 666 Shengli Road, Nantong, 226001, China.
Liu WS; Department of Endocrinology, Affiliated Hospital 2 of Nantong University and First People's Hospital of Nantong City, No. 666 Shengli Road, Nantong, 226001, China.
Wang LH; Department of Nursing, Affiliated Hospital 2 of Nantong University and First People's Hospital of Nantong City, No. 666 Shengli Road, Nantong, 226001, China.
Huang HY; Department of Endocrinology, Affiliated Hospital 2 of Nantong University and First People's Hospital of Nantong City, No. 666 Shengli Road, Nantong, 226001, China.
Wang XQ; Department of Endocrinology, Affiliated Hospital 2 of Nantong University and First People's Hospital of Nantong City, No. 666 Shengli Road, Nantong, 226001, China. .
Zhao LH; Department of Nursing, Affiliated Hospital 2 of Nantong University and First People's Hospital of Nantong City, No. 666 Shengli Road, Nantong, 226001, China. .
Xu F; Department of Endocrinology, Affiliated Hospital 2 of Nantong University and First People's Hospital of Nantong City, No. 666 Shengli Road, Nantong, 226001, China. .
Pokaż więcej
Źródło:
Nutrition journal [Nutr J] 2024 Mar 23; Vol. 23 (1), pp. 39. Date of Electronic Publication: 2024 Mar 23.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetic Nephropathies*/epidemiology
Diabetic Nephropathies*/etiology
Diabetic Nephropathies*/metabolism
Diabetes Mellitus, Type 2*/complications
Humans ; Nutrition Surveys ; Cross-Sectional Studies ; Kidney ; Glomerular Filtration Rate
Czasopismo naukowe
Tytuł:
Recent Advances in the Management of Diabetic Kidney Disease: Slowing Progression.
Autorzy:
Wang N; Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Zhang C; Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 07; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Diabetic Nephropathies*/drug therapy
Diabetic Nephropathies*/etiology
Renal Insufficiency, Chronic*/drug therapy
Renal Insufficiency, Chronic*/complications
Diabetes Mellitus, Type 2*/drug therapy
Humans ; Angiotensin-Converting Enzyme Inhibitors/pharmacology ; Angiotensin Receptor Antagonists/pharmacology ; Kidney/pathology
Czasopismo naukowe
Tytuł:
Cordyceps cicadae polysaccharides attenuate diabetic nephropathy via the miR-30a-3p/TRIM16 axis.
Autorzy:
Zheng R; Department of Nephrology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Xu Q; Department of Nephrology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Wang Y; Department of Nephrology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Zhong Y; Department of Nephrology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Zhu R; Department of Nephrology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Pokaż więcej
Źródło:
Journal of diabetes investigation [J Diabetes Investig] 2024 Mar; Vol. 15 (3), pp. 300-314. Date of Electronic Publication: 2023 Dec 27.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetic Nephropathies*/drug therapy
Diabetic Nephropathies*/prevention & control
Diabetes Mellitus, Type 2*
MicroRNAs*
Cordyceps*
Animals ; Mice ; Reactive Oxygen Species ; Antibodies ; Inflammation ; Luciferases ; Glucose
SCR Organism:
Cordyceps cicadae
Czasopismo naukowe
Tytuł:
Elevated plasma myoglobin level is closely associated with type 2 diabetic kidney disease.
Autorzy:
Yang L; Department of Nephrology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
Shen Y; Department of Endocrinology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
Li W; Department of Endocrinology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.; Center of Community-Based Health Research, Fudan University, Shanghai, China.; Jiangchuan Community Health Service Center, Shanghai, China.
Zha B; Department of Endocrinology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
Xu W; Department of Nephrology, Zhejiang Kaihua County Hospital of Chinese Medicine, Zhejiang, China.
Ding H; Department of Endocrinology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
Pokaż więcej
Źródło:
Journal of diabetes [J Diabetes] 2024 Mar; Vol. 16 (3), pp. e13508. Date of Electronic Publication: 2023 Nov 30.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetic Nephropathies*/diagnosis
Diabetic Nephropathies*/etiology
Diabetes Mellitus, Type 2*
Humans ; Myoglobin ; Glomerular Filtration Rate ; Kidney
Czasopismo naukowe
Tytuł:
Determinants of diabetic nephropathy among diabetic patients in Ethiopia: Systematic review and meta-analysis.
Autorzy:
Azagew AW; Department of Medical Nursing, School of Nursing, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Beko ZW; Department of Medical Nursing, School of Nursing, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Mekonnen CK; Department of Medical Nursing, School of Nursing, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Feb 02; Vol. 19 (2), pp. e0297082. Date of Electronic Publication: 2024 Feb 02 (Print Publication: 2024).
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Diabetic Nephropathies*/complications
Diabetic Nephropathies*/epidemiology
Hyperglycemia*/complications
Hypertension*/complications
Hypertension*/epidemiology
Diabetes Mellitus*/epidemiology
Humans ; Ethiopia/epidemiology ; Risk Factors ; Prevalence
Czasopismo naukowe
Tytuł:
Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetes.
Autorzy:
Gamez M; Bristol Renal, Bristol Medical School, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY, United Kingdom. .
Elhegni HE; Bristol Renal, Bristol Medical School, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY, United Kingdom.
Fawaz S; Bristol Renal, Bristol Medical School, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY, United Kingdom.
Ho KH; Department of Computer Science, Merchant Venturers Building, University of Bristol, Woodland Road, Bristol, BS8 1UB, United Kingdom.
Campbell NW; Department of Computer Science, Merchant Venturers Building, University of Bristol, Woodland Road, Bristol, BS8 1UB, United Kingdom.
Copland DA; Academic Unit of Ophthalmology, Translational Health Sciences, Bristol Medical School, University of Bristol, Biomedical Sciences Building, University Walk, Bristol, BS8 1TD, United Kingdom.
Onions KL; Bristol Renal, Bristol Medical School, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY, United Kingdom.
Butler MJ; Bristol Renal, Bristol Medical School, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY, United Kingdom.
Wasson EJ; Bristol Renal, Bristol Medical School, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY, United Kingdom.
Crompton M; Bristol Renal, Bristol Medical School, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY, United Kingdom.
Ramnath RD; Bristol Renal, Bristol Medical School, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY, United Kingdom.
Qiu Y; Bristol Renal, Bristol Medical School, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY, United Kingdom.
Yamaguchi Y; Sanford Burnham Prebys Medical Discovery Institute, 10901 North Torrey Pines Road, La Jolla, CA, 92037, USA.
Arkill KP; School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, NG7 2UH, United Kingdom.
Bates DO; School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, NG7 2UH, United Kingdom.
Turnbull JE; Centre for Glycoscience, School of Life Sciences, Keele University, Staffordshire, ST5 5BG, United Kingdom.
Zubkova OV; Ferrier Research Institute, Victoria University of Wellington, 69 Gracefield Rd, Lower Hutt, 5046, New Zealand.
Welsh GI; Bristol Renal, Bristol Medical School, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY, United Kingdom.
Atan D; Academic Unit of Ophthalmology, Translational Health Sciences, Bristol Medical School, University of Bristol, Biomedical Sciences Building, University Walk, Bristol, BS8 1TD, United Kingdom.; Bristol Eye Hospital, University Hospitals Bristol & Weston NHS Foundation Trust, Bristol, BS1 2LX, United Kingdom.
Satchell SC; Bristol Renal, Bristol Medical School, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY, United Kingdom.
Foster RR; Bristol Renal, Bristol Medical School, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY, United Kingdom.
Pokaż więcej
Źródło:
Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Feb 01; Vol. 23 (1), pp. 50. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Diabetic Nephropathies*/etiology
Diabetic Nephropathies*/prevention & control
Diabetic Angiopathies*/etiology
Diabetic Angiopathies*/prevention & control
Diabetic Angiopathies*/metabolism
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/metabolism
Glucuronidase*
Animals ; Mice ; Glycocalyx/metabolism ; Heparitin Sulfate/metabolism ; Heparitin Sulfate/pharmacology ; Albumins/pharmacology
Czasopismo naukowe
Tytuł:
Investigating the use of finerenone in children with chronic kidney disease and proteinuria: design of the FIONA and open-label extension studies.
Autorzy:
Schaefer F; Pediatric Nephrology Division, Heidelberg University Hospital, Heidelberg, Germany. .
Montini G; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.; Department of Pediatric Nephrology, Dialysis and Transplant Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Kang HG; Department of Pediatrics, Seoul National University College of Medicine, Seoul, South Korea.
Walle JV; Department of Pediatric Nephrology, Ghent University Hospital, Erknet Center, C4C, Ghent, Belgium.
Zaritsky J; Department of Nephrology, Phoenix Children's Hospital, Phoenix, AZ, USA.
Schreuder MF; Department of Pediatric Nephrology, Radboudumc Amalia Children's Hospital, Nijmegen, The Netherlands.
Litwin M; Department of Nephrology and Arterial Hypertension, Children's Memorial Health Institute, Warsaw, Poland.
Scalise A; Bayer Hispania, S.L, Sant Joan Despi, Barcelona, Spain.
Scott H; Bayer U.S Pharmaceuticals, Whippany, NJ, USA.
Potts J; Bayer U.S Pharmaceuticals, Whippany, NJ, USA.
Iveli P; Bayer AG, Wuppertal, Germany.
Breitenstein S; Bayer AG, Wuppertal, Germany.
Warady BA; Department of Pediatrics, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.; Children's Mercy Kansas City, Kansas City, MO, USA.
Pokaż więcej
Źródło:
Trials [Trials] 2024 Mar 21; Vol. 25 (1), pp. 203. Date of Electronic Publication: 2024 Mar 21.
Typ publikacji:
Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III; Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/drug therapy
Renal Insufficiency, Chronic*/complications
Renal Insufficiency, Chronic*/diagnosis
Renal Insufficiency, Chronic*/drug therapy
Diabetic Nephropathies*/drug therapy
Naphthyridines*
Adult ; Humans ; Child ; Angiotensin Receptor Antagonists/therapeutic use ; Angiotensin-Converting Enzyme Inhibitors/adverse effects ; Proteinuria/drug therapy ; Proteinuria/chemically induced ; Mineralocorticoid Receptor Antagonists/adverse effects
Czasopismo naukowe
Tytuł:
Jian-Pi-Gu-Shen-Hua-Yu Decoction Alleviated Diabetic Nephropathy in Mice through Reducing Ferroptosis.
Autorzy:
Lv S; Cangzhou Hospital of Integrated Traditional Chinese Medicine and Western Medicine of Hebei, Cangzhou 061012, Hebei, China.
Fan L; Botou Hospital of Traditional Chinese Medicine, Botou 062154, Hebei, China.
Chen X; Cangzhou Hospital of Integrated Traditional Chinese Medicine and Western Medicine of Hebei, Cangzhou 061012, Hebei, China.
Su X; Cangzhou Hospital of Integrated Traditional Chinese Medicine and Western Medicine of Hebei, Cangzhou 061012, Hebei, China.
Dong L; Cangzhou Hospital of Integrated Traditional Chinese Medicine and Western Medicine of Hebei, Cangzhou 061012, Hebei, China.
Wang Q; Cangzhou Hospital of Integrated Traditional Chinese Medicine and Western Medicine of Hebei, Cangzhou 061012, Hebei, China.
Wang Y; Cangzhou Hospital of Integrated Traditional Chinese Medicine and Western Medicine of Hebei, Cangzhou 061012, Hebei, China.
Zhang H; Cangzhou Hospital of Integrated Traditional Chinese Medicine and Western Medicine of Hebei, Cangzhou 061012, Hebei, China.
Cui H; Yunnan University of Chinese Medicine, Kunming 650500, Yunnan, China.
Zhang S; Cangzhou Hospital of Integrated Traditional Chinese Medicine and Western Medicine of Hebei, Cangzhou 061012, Hebei, China.
Wang L; Cangzhou Hospital of Integrated Traditional Chinese Medicine and Western Medicine of Hebei, Cangzhou 061012, Hebei, China.
Pokaż więcej
Źródło:
Journal of diabetes research [J Diabetes Res] 2024 Mar 16; Vol. 2024, pp. 9990304. Date of Electronic Publication: 2024 Mar 16 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Diabetic Nephropathies*/drug therapy
Ferroptosis*
Iron Overload*/complications
Iron Overload*/drug therapy
Diabetes Mellitus*
Animals ; Mice ; Disease Models, Animal ; Inflammation
Czasopismo naukowe
Tytuł:
Association between Albumin Alterations and Renal Function in Patients with Type 2 Diabetes Mellitus.
Autorzy:
Nugnes M; Department of Pharmacy and Biotechnology, Alma Mater Studiorum University of Bologna, 40126 Bologna, Italy.
Baldassarre M; Unit of Semeiotics, Liver and Alcohol-Related Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Ribichini D; Endocrinology and Diabetes Prevention and Care Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Tedesco D; Department of Pharmacy and Biotechnology, Alma Mater Studiorum University of Bologna, 40126 Bologna, Italy.; Institute for Organic Synthesis and Photoreactivity, National Research Council, 40129 Bologna, Italy.
Capelli I; Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, 40126 Bologna, Italy.; Nephrology, Dialysis and Renal Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Vetrano D; Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, 40126 Bologna, Italy.; Nephrology, Dialysis and Renal Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Marchignoli F; Unit of Clinical Nutrition, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Brodosi L; Unit of Clinical Nutrition, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Pompili E; Unit of Semeiotics, Liver and Alcohol-Related Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.; Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, 40126 Bologna, Italy.
Petroni ML; Unit of Clinical Nutrition, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
La Manna G; Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, 40126 Bologna, Italy.; Nephrology, Dialysis and Renal Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Marchesini G; Unit of Clinical Nutrition, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Naldi M; Department of Pharmacy and Biotechnology, Alma Mater Studiorum University of Bologna, 40126 Bologna, Italy.; Centre for Applied Biomedical Research (CRBA), Alma Mater Studiorum University of Bologna, 40126 Bologna, Italy.
Bartolini M; Department of Pharmacy and Biotechnology, Alma Mater Studiorum University of Bologna, 40126 Bologna, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 09; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 09.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/complications
Diabetic Nephropathies*/complications
Humans ; Glomerular Filtration Rate ; Sensitivity and Specificity ; Kidney
Czasopismo naukowe
Tytuł:
Application of hospital-community-home linkage management model in patients with type 2 diabetic nephropathy.
Autorzy:
Xu HM; Department of Education, Shanxi Bethune Hospital, Taiyuan, 030032, Shanxi, China.
Zhai YP; Department of Internal Medicine, Shanxi Bethune Hospital, Xiaodian District, 99 Longcheng Street, Taiyuan, 030032, Shanxi, China. zhaiyp_.
Zhu WJ; Department of Nursing, Shanxi Bethune Hospital, Taiyuan, 030032, Shanxi, China.
Li M; Department of Breast Surgery, Shanxi Bethune Hospital, Taiyuan, 030032, Shanxi, China.
Wu ZP; Department of Education, Shanxi Bethune Hospital, Taiyuan, 030032, Shanxi, China.
Wang P; Department of Nursing, Taiyuan City Central Hospital, Taiyuan, 030009, Shanxi, China.
Wang XJ; Department of Nursing, Shanxi Bethune Hospital, Taiyuan, 030032, Shanxi, China.
Pokaż więcej
Źródło:
Journal of health, population, and nutrition [J Health Popul Nutr] 2024 Mar 07; Vol. 43 (1), pp. 40. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetic Nephropathies*/therapy
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/therapy
Humans ; Blood Glucose ; Patient Compliance ; Hospitals
Czasopismo naukowe
Tytuł:
Amelioration of diabetic nephropathy in mice by a single intravenous injection of human mesenchymal stromal cells at early and later disease stages is associated with restoration of autophagy.
Autorzy:
He J; Hebei Medical University-University of Galway Stem Cell Research Center, Hebei Medical University, Shijiazhuang, 050017, Hebei Province, China.; Hebei Research Center for Stem Cell Medical Translational Engineering, Shijiazhuang, 050017, Hebei Province, China.; Hebei Technology Innovation Center for Stem Cell and Regenerative Medicine, Shijiazhuang, 050017, Hebei Province, China.; Hebei International Joint Research Center for Stem Cell and Regenerative Medicine, Shijiazhuang, 050017, Hebei Province, China.
Liu B; Hebei Medical University-University of Galway Stem Cell Research Center, Hebei Medical University, Shijiazhuang, 050017, Hebei Province, China.; Hebei Research Center for Stem Cell Medical Translational Engineering, Shijiazhuang, 050017, Hebei Province, China.; Hebei Technology Innovation Center for Stem Cell and Regenerative Medicine, Shijiazhuang, 050017, Hebei Province, China.; Hebei International Joint Research Center for Stem Cell and Regenerative Medicine, Shijiazhuang, 050017, Hebei Province, China.
Du X; Hebei Medical University-University of Galway Stem Cell Research Center, Hebei Medical University, Shijiazhuang, 050017, Hebei Province, China.; Hebei Research Center for Stem Cell Medical Translational Engineering, Shijiazhuang, 050017, Hebei Province, China.; Hebei Technology Innovation Center for Stem Cell and Regenerative Medicine, Shijiazhuang, 050017, Hebei Province, China.; Hebei International Joint Research Center for Stem Cell and Regenerative Medicine, Shijiazhuang, 050017, Hebei Province, China.
Wei Y; Hebei Medical University-University of Galway Stem Cell Research Center, Hebei Medical University, Shijiazhuang, 050017, Hebei Province, China.; Hebei Research Center for Stem Cell Medical Translational Engineering, Shijiazhuang, 050017, Hebei Province, China.; Hebei Technology Innovation Center for Stem Cell and Regenerative Medicine, Shijiazhuang, 050017, Hebei Province, China.; Hebei International Joint Research Center for Stem Cell and Regenerative Medicine, Shijiazhuang, 050017, Hebei Province, China.
Kong D; Hebei Medical University-University of Galway Stem Cell Research Center, Hebei Medical University, Shijiazhuang, 050017, Hebei Province, China.; Hebei Research Center for Stem Cell Medical Translational Engineering, Shijiazhuang, 050017, Hebei Province, China.; Hebei Technology Innovation Center for Stem Cell and Regenerative Medicine, Shijiazhuang, 050017, Hebei Province, China.; Hebei International Joint Research Center for Stem Cell and Regenerative Medicine, Shijiazhuang, 050017, Hebei Province, China.
Feng B; Hebei Medical University-University of Galway Stem Cell Research Center, Hebei Medical University, Shijiazhuang, 050017, Hebei Province, China.; Hebei Research Center for Stem Cell Medical Translational Engineering, Shijiazhuang, 050017, Hebei Province, China.; Hebei Technology Innovation Center for Stem Cell and Regenerative Medicine, Shijiazhuang, 050017, Hebei Province, China.; Hebei International Joint Research Center for Stem Cell and Regenerative Medicine, Shijiazhuang, 050017, Hebei Province, China.; Human Anatomy Department, Hebei Medical University, Shijiazhuang, 050017, Hebei Province, China.
Guo R; Hebei Medical University-University of Galway Stem Cell Research Center, Hebei Medical University, Shijiazhuang, 050017, Hebei Province, China.; Hebei Research Center for Stem Cell Medical Translational Engineering, Shijiazhuang, 050017, Hebei Province, China.; Hebei Technology Innovation Center for Stem Cell and Regenerative Medicine, Shijiazhuang, 050017, Hebei Province, China.; Hebei International Joint Research Center for Stem Cell and Regenerative Medicine, Shijiazhuang, 050017, Hebei Province, China.
Asiamah EA; Hebei Medical University-University of Galway Stem Cell Research Center, Hebei Medical University, Shijiazhuang, 050017, Hebei Province, China.; Hebei Research Center for Stem Cell Medical Translational Engineering, Shijiazhuang, 050017, Hebei Province, China.; Hebei Technology Innovation Center for Stem Cell and Regenerative Medicine, Shijiazhuang, 050017, Hebei Province, China.; Hebei International Joint Research Center for Stem Cell and Regenerative Medicine, Shijiazhuang, 050017, Hebei Province, China.; Department of Forensic Sciences, College of Agriculture and Natural Sciences, University of Cape Coast, PMB UCC, Cape Coast, Ghana.
Griffin MD; Hebei Medical University-University of Galway Stem Cell Research Center, Hebei Medical University, Shijiazhuang, 050017, Hebei Province, China.; Regenerative Medicine Institute (REMEDI) at CÚRAM SFI Research Centre for Medical Devices, School of Medicine, University of Galway, Galway, Ireland.
Hynes SO; Discipline of Pathology, School of Medicine, University of Galway, Galway, Ireland.
Shen S; Hebei Medical University-University of Galway Stem Cell Research Center, Hebei Medical University, Shijiazhuang, 050017, Hebei Province, China.; Regenerative Medicine Institute (REMEDI) at CÚRAM SFI Research Centre for Medical Devices, School of Medicine, University of Galway, Galway, Ireland.
Liu Y; Department of Endocrinology, Hebei Medical University Third Affiliated Hospital, Shijiazhuang, 050051, Hebei, China.
Cui H; Hebei Medical University-University of Galway Stem Cell Research Center, Hebei Medical University, Shijiazhuang, 050017, Hebei Province, China.; Hebei Research Center for Stem Cell Medical Translational Engineering, Shijiazhuang, 050017, Hebei Province, China.; Hebei Technology Innovation Center for Stem Cell and Regenerative Medicine, Shijiazhuang, 050017, Hebei Province, China.; Hebei International Joint Research Center for Stem Cell and Regenerative Medicine, Shijiazhuang, 050017, Hebei Province, China.; Human Anatomy Department, Hebei Medical University, Shijiazhuang, 050017, Hebei Province, China.
Ma J; Hebei Medical University-University of Galway Stem Cell Research Center, Hebei Medical University, Shijiazhuang, 050017, Hebei Province, China. .; Hebei Research Center for Stem Cell Medical Translational Engineering, Shijiazhuang, 050017, Hebei Province, China. .; Hebei Technology Innovation Center for Stem Cell and Regenerative Medicine, Shijiazhuang, 050017, Hebei Province, China. .; Hebei International Joint Research Center for Stem Cell and Regenerative Medicine, Shijiazhuang, 050017, Hebei Province, China. .; Human Anatomy Department, Hebei Medical University, Shijiazhuang, 050017, Hebei Province, China. .
O'Brien T; Hebei Medical University-University of Galway Stem Cell Research Center, Hebei Medical University, Shijiazhuang, 050017, Hebei Province, China. .; Regenerative Medicine Institute (REMEDI) at CÚRAM SFI Research Centre for Medical Devices, School of Medicine, University of Galway, Galway, Ireland. .
Pokaż więcej
Źródło:
Stem cell research & therapy [Stem Cell Res Ther] 2024 Mar 05; Vol. 15 (1), pp. 66. Date of Electronic Publication: 2024 Mar 05.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetic Nephropathies*/therapy
Diabetes Mellitus, Experimental*/therapy
Mesenchymal Stem Cells*
Urogenital Abnormalities*
Kidney/*abnormalities
Humans ; Animals ; Mice ; Mice, Inbred C57BL ; Injections, Intravenous ; Transforming Growth Factor beta1 ; Interleukin-6 ; Tumor Necrosis Factor-alpha ; Autophagy ; Fibrosis ; TOR Serine-Threonine Kinases
SCR Disease Name:
Renal Adysplasia
Czasopismo naukowe
Tytuł:
Predictive model for identifying mild cognitive impairment in patients with type 2 diabetes mellitus: A CHAID decision tree analysis.
Autorzy:
Maimaitituerxun R; Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, Hunan, China.
Chen W; Department of Nephrology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Xiang J; Department of Human Resources, Jinan Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Xie Y; Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, Hunan, China.
Xiao F; Department of Toxicology, Xiangya School of Public Health, Central South University, Changsha, Hunan, China.
Wu XY; Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, Hunan, China.
Chen L; Infection Control Center, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Yang J; Department of Preventive Medicine, Changzhi Medical College, Changzhi, Shanxi, China.
Liu A; Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, Hunan, China.
Dai W; Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, Hunan, China.
Pokaż więcej
Źródło:
Brain and behavior [Brain Behav] 2024 Mar; Vol. 14 (3), pp. e3456.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/complications
Diabetic Nephropathies*
Diabetic Retinopathy*
Cognitive Dysfunction*/diagnosis
Cognitive Dysfunction*/etiology
Humans ; Middle Aged ; Aged ; Case-Control Studies ; Decision Trees
Czasopismo naukowe
Tytuł:
METTL3/YTHDF2 m6A axis mediates the progression of diabetic nephropathy through epigenetically suppressing PINK1 and mitophagy.
Autorzy:
Wang F; Department of Functional Medicine, School of Basic Medical Sciences, Jiamusi University, Jiamusi, China.; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases School of Basic Medicine, Jiamusi University, Jiamusi, China.
Bai J; Department of Anesthesiology and Center for Brain Science, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Zhang X; First Affiliated Hospital of Jiamusi University, Jiamusi, China.; Department of Endocrinology, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, China.
Wang D; Department of Ophthalmology, The First Affiliated Hospital of Jiamusi University, Jiamusi, China.
Zhang X; Department of Pathophysiology, School of Basic Medical Sciences, Jiamusi University, Jiamusi, China.
Xue J; Department of Pathophysiology, School of Basic Medical Sciences, Jiamusi University, Jiamusi, China.
Chen H; First Affiliated Hospital of Jiamusi University, Jiamusi, China.
Wang S; Department of Functional Medicine, School of Basic Medical Sciences, Jiamusi University, Jiamusi, China.
Chi B; Department of Urology, First Affiliated Hospital of Jiamusi University, Jiamusi, China.
Li J; Department of Functional Medicine, School of Basic Medical Sciences, Jiamusi University, Jiamusi, China.
Ma X; Department of Functional Medicine, School of Basic Medical Sciences, Jiamusi University, Jiamusi, China.; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases School of Basic Medicine, Jiamusi University, Jiamusi, China.
Pokaż więcej
Źródło:
Journal of diabetes investigation [J Diabetes Investig] 2024 Mar; Vol. 15 (3), pp. 288-299. Date of Electronic Publication: 2023 Nov 28.
Typ publikacji:
Journal Article
MeSH Terms:
Adenine*/analogs & derivatives
Diabetes Mellitus*
Diabetic Nephropathies*/genetics
Animals ; Mice ; Interleukin-6 ; Mitophagy ; Protein Kinases ; Reactive Oxygen Species ; RNA, Messenger ; Tumor Necrosis Factor-alpha ; Humans
Czasopismo naukowe
Tytuł:
Crosstalk among podocytes, glomerular endothelial cells and mesangial cells in diabetic kidney disease: an updated review.
Autorzy:
Hu S; Institute of Metabolic Diseases, Guang' anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.; Beijing University of Chinese Medicine, Beijing, 100029, China.
Hang X; Institute of Metabolic Diseases, Guang' anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.; Beijing University of Chinese Medicine, Beijing, 100029, China.
Wei Y; Institute of Metabolic Diseases, Guang' anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.; Beijing University of Chinese Medicine, Beijing, 100029, China.
Wang H; Beijing University of Chinese Medicine, Beijing, 100029, China. .
Zhang L; Institute of Metabolic Diseases, Guang' anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China. .
Zhao L; Institute of Metabolic Diseases, Guang' anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China. .
Pokaż więcej
Źródło:
Cell communication and signaling : CCS [Cell Commun Signal] 2024 Feb 19; Vol. 22 (1), pp. 136. Date of Electronic Publication: 2024 Feb 19.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Podocytes*/pathology
Diabetic Nephropathies*/metabolism
Diabetes Mellitus*/pathology
Humans ; Mesangial Cells/metabolism ; Endothelial Cells/metabolism ; Kidney Glomerulus/pathology
Czasopismo naukowe
Tytuł:
High CD133 expression in proximal tubular cells in diabetic kidney disease: good or bad?
Autorzy:
Zhang Y; Department of Endocrinology and Metabology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, 250014, China.; Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shandong, China.; Shandong Key Laboratory of Endocrinology and Lipid Metabolism, Jinan, 250021, Shandong, China.
Xu L; Department of Endocrinology and Metabology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, 250014, China.
Guo C; Department of Endocrinology and Metabology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, 250014, China.
Li X; Department of Endocrinology and Metabology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, 250014, China.
Tian Y; Department of Endocrinology and Metabology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, 250014, China.
Liao L; Department of Endocrinology and Metabology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, 250014, China. .
Dong J; Division of Endocrinology, Department of Internal Medicine, Qilu Hospital of Shandong University, Jinan, 250012, China. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2024 Feb 16; Vol. 22 (1), pp. 159. Date of Electronic Publication: 2024 Feb 16.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus*/pathology
Diabetic Nephropathies*/metabolism
AC133 Antigen*/genetics
AC133 Antigen*/metabolism
Animals ; Humans ; Rats ; Cell Line ; Cell Proliferation ; Epithelial Cells/pathology ; Glucose/metabolism ; Hyperplasia/pathology
Czasopismo naukowe
Tytuł:
Exploring the relations of NLR, hsCRP and MCP-1 with type 2 diabetic kidney disease: a cross-sectional study.
Autorzy:
Fang Y; Department of Nephrology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Liqizhuang Street, Xiqing District, Tianjin, 300380, China.; Department of Nephrology, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
Wang B; Department of Endocrinology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.; Department of Endocrinology, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
Pang B; Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Zhou Z; Department of Nephrology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Liqizhuang Street, Xiqing District, Tianjin, 300380, China.; Department of Nephrology, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
Xing Y; Department of Nephrology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Liqizhuang Street, Xiqing District, Tianjin, 300380, China.; Department of Nephrology, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
Pang P; Department of Endocrinology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.; Department of Endocrinology, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
Zheng D; Department of Nephrology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Liqizhuang Street, Xiqing District, Tianjin, 300380, China.; Department of Nephrology, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
Zhang G; The Community Health Service Center of Hangzhou Road Street in Tianjin Binhai New Area, Tianjin, China.
Yang B; Department of Nephrology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Liqizhuang Street, Xiqing District, Tianjin, 300380, China. .; Department of Nephrology, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 08; Vol. 14 (1), pp. 3211. Date of Electronic Publication: 2024 Feb 08.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/complications
Diabetic Nephropathies*/urine
Humans ; C-Reactive Protein/analysis ; Chemokine CCL2/urine ; Cross-Sectional Studies ; Lymphocytes/chemistry ; Neutrophils/chemistry ; Retrospective Studies ; ROC Curve
Czasopismo naukowe
Tytuł:
Evaluation of changes in glycemic control and diabetic complications over time and factors associated with the progression of diabetic complications in Japanese patients with juvenile-onset type 1 diabetes mellitus.
Autorzy:
Masuda T; Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Katakami N; Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Watanabe H; Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Taya N; Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Miyashita K; Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Takahara M; Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.; Department of Diabetes Care Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Kato K; Diabetes Center, NHO Osaka National Hospital, Osaka, Japan.
Kuroda A; Diabetes Therapeutics and Research Center, Institute of Advance Medical Sciences, Tokushima University, Tokushima, Japan.
Matsuhisa M; Diabetes Therapeutics and Research Center, Institute of Advance Medical Sciences, Tokushima University, Tokushima, Japan.
Shimomura I; Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Pokaż więcej
Źródło:
Journal of diabetes [J Diabetes] 2024 Feb; Vol. 16 (2), pp. e13486. Date of Electronic Publication: 2023 Oct 18.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Diabetes Mellitus, Type 1*/complications
Diabetes Mellitus, Type 2*
Diabetes Complications*/complications
Diabetic Nephropathies*/complications
Humans ; Adolescent ; Young Adult ; Adult ; Glycated Hemoglobin ; Carotid Intima-Media Thickness ; Ankle Brachial Index/adverse effects ; Glycemic Control/adverse effects ; Glycated Serum Albumin ; Japan ; Pulse Wave Analysis/adverse effects ; Cholesterol ; Risk Factors
Czasopismo naukowe
Tytuł:
Circ_0068087 knockdown attenuates high-glucose-induced human tubular epithelial cell injury in a microribonucleic acid/progestin and adipoQ receptor 3-dependent manner in diabetic nephropathy.
Autorzy:
Liu SY; Department of Endocrinology, The First Affiliated Hospital of Henan Polytechnic University (Jiaozuo Second People's Hospital), Jiaozuo, China.
Wang H; Department of Gynecology, The First Affiliated Hospital of Henan Polytechnic University (Jiaozuo Second People's Hospital), Jiaozuo, China.
Yang B; Department of Neurology, The First Affiliated Hospital of Henan Polytechnic University (Jiaozuo Second People's Hospital), Jiaozuo, China.
Hou B; Medical College of Henan Polytechnic University, Jiaozuo, China.
Sun LS; Department of Gynecology, The First Affiliated Hospital of Henan Polytechnic University (Jiaozuo Second People's Hospital), Jiaozuo, China.
Pang H; Department of Oncology, The First Affiliated Hospital of Henan Polytechnic University (Jiaozuo Second People's Hospital), Jiaozuo, China.
Wang HH; Department of Endocrinology, The First Affiliated Hospital of Henan Polytechnic University (Jiaozuo Second People's Hospital), Jiaozuo, China.
Fan YP; Department of Endocrinology, The First Affiliated Hospital of Henan Polytechnic University (Jiaozuo Second People's Hospital), Jiaozuo, China.
Pokaż więcej
Źródło:
Journal of diabetes investigation [J Diabetes Investig] 2024 Feb; Vol. 15 (2), pp. 159-171. Date of Electronic Publication: 2023 Nov 20.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetic Nephropathies*/genetics
MicroRNAs*/genetics
Diabetes Mellitus*
Humans ; Progestins ; Epithelial Cells ; Apoptosis ; Cell Proliferation ; Glucose/pharmacology
Czasopismo naukowe
Tytuł:
Relationship between elevated circulating thrombospondin-1 levels and vascular complications in diabetes mellitus.
Autorzy:
Guo N; Graduate School of Hebei North University, Zhangjiakou, China.
Yang L; Hebei Key Laboratory of Metabolic Diseases, Hebei General Hospital, Shijiazhuang, China.
Wan X; Graduate School of Hebei North University, Zhangjiakou, China.; Department of Endocrinology, Hebei General Hospital, Shijiazhuang, China.
Qiu D; Department of Endocrinology, Hebei General Hospital, Shijiazhuang, China.; Graduate School of Hebei Medical University, Shijiazhuang, China.
Sun W; Department of Endocrinology, Hebei General Hospital, Shijiazhuang, China.; Graduate School of North China University of Science and Technology, Tangshan, China.
Ma H; Hebei Key Laboratory of Metabolic Diseases, Hebei General Hospital, Shijiazhuang, China.; Department of Endocrinology, Hebei General Hospital, Shijiazhuang, China.
Pokaż więcej
Źródło:
Journal of diabetes investigation [J Diabetes Investig] 2024 Feb; Vol. 15 (2), pp. 197-207. Date of Electronic Publication: 2023 Oct 11.
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
Cardiovascular Diseases*
Diabetes Mellitus*
Diabetic Angiopathies*/etiology
Diabetic Nephropathies*/pathology
Diabetic Retinopathy*/etiology
Humans ; Thrombospondin 1/metabolism
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies